Holen Sie sich die Stockscreener-App
1.90
4.61%
-0.10
Schlusskurs vom Vortag:
$2.00
Offen:
$1.94
24-Stunden-Volumen:
84,963
Relative Volume:
0.11
Marktkapitalisierung:
$129.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-64.20M
KGV:
-0.8837
EPS:
-2.15
Netto-Cashflow:
$57,000
1W Leistung:
-8.28%
1M Leistung:
-3.65%
6M Leistung:
+50.22%
1J Leistung:
-45.65%
1-Tages-Spanne:
$1.90
$1.97
1-Wochen-Bereich:
$1.90
$2.18
52-Wochen-Spanne:
$1.05
$4.34
Climb Bio Inc Stock (CLYM) Company Profile
Firmenname
Climb Bio Inc
Sektor
Branche
Telefon
1-866-857-2596
Adresse
20 WILLIAM STREET, WELLESLEY HILLS
Vergleichen Sie CLYM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLYM
Climb Bio Inc
|
1.905 | 135.53M | 0 | -64.20M | 57,000 | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.48 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
633.37 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
427.20 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
843.29 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.65 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Climb Bio Inc Stock (CLYM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-16 | Eingeleitet | William Blair | Outperform |
| 2025-10-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-08-15 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-06-06 | Eingeleitet | Oppenheimer | Outperform |
| 2025-05-22 | Eingeleitet | BTIG Research | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Climb Bio Inc Aktie (CLYM) Neueste Nachrichten
Can momentum traders help lift Climb Bio Inc.July 2025 Fed Impact & Stock Portfolio Risk Management - newser.com
How sustainable is Climb Bio Inc. stock dividend payoutEarnings Beat & Risk Controlled Swing Trade Alerts - newser.com
Will Climb Bio Inc. stock go up soonWeekly Loss Report & AI Based Buy/Sell Signal Reports - newser.com
Is Climb Bio Inc. stock entering bullish territoryEarnings Recap Summary & Real-Time Volume Analysis Alerts - newser.com
Why Climb Bio Inc. stock is recommended by analystsJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Can Climb Bio Inc. stock maintain operating margins2025 Market Outlook & Fast Momentum Stock Entry Tips - newser.com
Visualizing Climb Bio Inc. stock with heatmapsJuly 2025 Levels & Low Drawdown Momentum Ideas - newser.com
Momentum divergence signals in Climb Bio Inc. chartSell Signal & Verified Stock Trade Ideas - newser.com
Climb Bio to Present at Upcoming Investor Conferences - The Manila Times
Climb Bio (Nasdaq: CLYM) to join Guggenheim, Baird and Piper Sandler events; webcasts - Stock Titan
Using R and stats models for Climb Bio Inc. forecastingWeekly Stock Report & Community Consensus Stock Picks - newser.com
Predicting Climb Bio Inc. trend using moving averagesQuarterly Trade Summary & Advanced Swing Trade Entry Alerts - newser.com
Strategies to average down on Climb Bio Inc.Analyst Downgrade & Reliable Price Action Trade Plans - newser.com
Has Climb Bio Inc. formed a bullish divergenceMarket Rally & Risk Managed Investment Strategies - newser.com
What institutional flow reveals about Climb Bio Inc.Weekly Investment Summary & Community Consensus Stock Picks - newser.com
William Blair Initiates Coverage of Climb Bio (CLYM) with Outperform Rating on Autoimmune Drug Potential - Insider Monkey
10 Best Stocks Under $3 to Invest In - Insider Monkey
Climb Bio, Inc. (NASDAQ:CLYM) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Finanzdaten der Climb Bio Inc-Aktie (CLYM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Climb Bio Inc-Aktie (CLYM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Pimblett Emily | SVP, Finance & CAO |
Jun 20 '25 |
Sale |
1.24 |
1,242 |
1,540 |
18,888 |
| Pimblett Emily | SVP, Finance & CAO |
Mar 20 '25 |
Sale |
1.31 |
1,199 |
1,571 |
15,130 |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER |
Dec 19 '24 |
Sale |
2.02 |
1,235 |
2,495 |
11,329 |
1.68%
0.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):